1 |
EG |
Download |
Egypt J Pediatr Allergy Immunol |
|
2008 |
; |
6 |
( |
01 |
) |
: |
13-25 |
- |
|
|
, |
ESP - 54 |
|
|
|
Monocyte chemotactic protein-4 (MCP-4/CCL-13) and CC chemokine
receptor 3 (CCR3) in the sputum of asthmatic children |
Yehia M. El-Gamal |
|
Mohamed H. Ezzat |
|
Khaled S. Awwad |
|
Nahla M. Heshmat |
|
Manal M. Abd Al-Aziz |
|
Zeinab M. El-Gabbas |
|
|
Background: Monocyte chemotactic protein-4 (MCP-4/CCL-13) is a potent
chemoattractant to eosinophils, monocytes and lymphocytes.
Objective: We aimed to investigate MCP-4 and its CC chemokine receptor 3
(CCR3) expression on cells of induced sputum during acute asthma
exacerbation.
Methods: Immunohistochemistry was used to assess MCP-4 and CCR3
expression on induced sputum cells of 30 children during asthma
exacerbation and 20 healthy matched controls. Patients were divided into
three groups according to exacerbation severity; mild, moderate and severe
(n = 10 for each). Patients were followed until quiescence, when sputum was
re-examined.
Results: MCP-4 and CCR3 were expressed on eosinophils and monocytes.
Lymphocytes expressed only MCP-4. The percentages of sputum total cells,
eosinophils and lymphocytes expressing MCP-4 and/or CCR3 were
significantly higher during asthma exacerbation than in controls and
negatively correlated with peak expiratory flow rate, whereas that of
monocytes was not. The percentages of sputum total cells, eosinophils,
monocytes and lymphocytes expressing MCP-4; and total cells and
eosinophils expressing CCR3 were significantly higher in patients with
severe than those with mild and moderate exacerbations. When patients
were followed till remission, the percentages of sputum cells expressing
MCP-4 and CCR3 decreased. Sputum eosinophil percentage correlated
positively with the percentage of eosinophils expressing MCP-4 and CCR3
(r = 0.69, p < 0.0001; r = 0.62, p < 0.001, respectively). The percentage of
sputum eosinophils expressing MCP-4 correlated positively with that of cells
expressing CCR3 (r = 0.95, p < 0.0001).
Conclusion: The expression of MCP-4 and CCR3 on sputum cells increases
during acute asthma exacerbation and this increase correlates with
exacerbation severity, and it decreases during remission. Modification of
their expression could be a potential target for asthma therapy. |
|